Other Species / Isoforms
  SLAM (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S73-p
MAKSLENsVENKIVS
0 1
SLAM (human) MAKSLENsVENKIVS S73-p
SLAM (mouse) gap -
-
under review
0 1
SLAM (human) under review -
SLAM (mouse) SSISRTFnLSSQACK N226-ng
T272-p
KTNHYQTtVEKKsLt
0 1
SLAM (human) KTNHYQTtVEKKsLt T272-p
SLAM (mouse) KSNHCQPPVEEKSLT P279
S277-p
QTtVEKKsLtIyAQV
0 3
SLAM (human) QTtVEKKsLtIyAQV S277-p
SLAM (mouse) QPPVEEKSLTIyAQV S284
T279-p
tVEKKsLtIyAQVQK
0 5
SLAM (human) tVEKKsLtIyAQVQK T279-p
SLAM (mouse) PVEEKSLTIyAQVQK T286
Y281-p
EKKsLtIyAQVQKPG
Upstream
Downstream
2 747
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • Fyn (human)
Treatment
  • anti-CD3
SLAM (human) EKKsLtIyAQVQKPG Y281-p
SLAM (mouse) EEKSLTIyAQVQKSG Y288-p
Y307-p
QDPCTTIyVAATEPV
Upstream
2 0
Putative in vivo kinases:
  • Fyn (human)
  • Lck (human)
Treatment
  • anti-CD3
SLAM (human) QDPCTTIyVAATEPV Y307-p
SLAM (mouse) QDPCTTIyVAATEPA Y315-p
Y327-p
ETNSITVyASVTLPE
Upstream
Downstream
3 0
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • LYN (human)
Putative in vivo kinases:
  • Fyn (human)
  • LYN (human)
Treatment
  • anti-CD150
  • anti-CD3
SLAM (human) ETNSITVyASVTLPE Y327-p
SLAM (mouse) EPNPTTVyASVTLPE Y335-p